Target
vinblastine
11 abstracts
Abstract
Seven-year overall survival analysis from ECHELON-1 study of A+AVD versus ABVD in patients with previously untreated stage III/IV classical Hodgkin lymphoma.Org: Antoine-Lacassagne Cancer Center, University of Tennessee Graduate School of Medicine, Takeda Pharmaceuticals International AG,
Abstract
Predictive cytokine biomarkers for immune-related adverse events associated with immune checkpoint inhibitor therapy in Hodgkin lymphoma.Org: NYU Langone Medical Center, NYU Langone Health, New York, NY, Perlmutter Cancer Center, New York University Langone Health,
Abstract
Cisplatin-vinblastine-temozolomide regimen for patients with relapsed-refractory melanoma who are ineligible for clinical trials: A tertiary care center experience.Org: University Hospitals Seidman Cancer Center, University Hospitals Case Medical Center Rehabilitation Services, University Hospitals Cleveland Medical Center, University Hospitals Sussex NHS Foundation Trust,
Abstract
Phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 in early stage breast cancer: The INVINCIBLE trial.Org: Ontario Institute for Cancer Research, Toronto, ON, Canada, The University of Ottawa, The Ottawa Hospital Research Institute, McGill University Health Centre, McMaster University and Juravinski Cancer Centre,
Abstract
Survival outcomes in patients with muscle-invasive bladder cancer receiving neoadjuvant chemotherapy stratified by number of cycles.Org: Temple University Health System, Fox Chase Cancer Center, Temple Health,
Abstract
Outcomes in pediatric relapsed/refractory anaplastic large cell lymphoma: A multi-institutional retrospective analysis.Org: Stanford University School of Medicine, Children's Hospital of The King's Daughters Surgical Group,
Abstract
Brentuximab vedotin + AVD for newly diagnosed classic Hodgkin lymphoma (cHL): Incidence and management of peripheral neuropathy in a multi-institution cohort.Org: Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, University of Colorado Denver Anschutz Medical Center, Aurora, CO,
Abstract
Intratumoral INT230-6 (cisplatin, vinblastine, shao) alone or with ipilimumab prolonged survival with favorable safety in adults with refractory sarcomas.Org: Johns Hopkins Hospital, Columbia University Irving Medical Center, New York, NY, USA, Division of Oncology, Norris Comprehensive Cancer Center, University of Southern California, University of Massachusetts Memorial Medical Center, University of Southern California, Norris Comprehensive Cancer Center,
Abstract
Evaluating access to brentuximab in elderly patients with Hodgkin lymphoma.Org: University of Florida College of Medicine Jacksonville, University of Florida College of Pharmacy, University of Florida College of Public Health and Health Professions,
Abstract
Presentation of congenital soft-tissue sarcomas: A single institution experience.Org: Nicklaus Children's Hospital, Nicklaus Children's Hospital Department of Pathology,
Abstract
Cost-effective analysis of rotational intraperitoneal aerosol chemotherapy (RIPAC) in patients with platinum-resistant ovarian cancer.Org: Seoul National University Hospital, Seoul National University College of Medicine,